基本信息
views: 0
Career Trajectory
Bio
Colman's research interests are in structural biology, especially of human B-cell lymphoma 2 (BCL-2). Colman determined the three-dimensional structure of the influenza virus neuraminidase and, in one of the earliest cases of structure-based drug design, discovered zanamivir, the first-in-class neuraminidase inhibitor for influenza. His subsequent structural studies on resistance to this drug class suggested how to design drugs against moving targets. His discoveries underpin drug stockpiling for pandemic preparedness. He has made seminal contributions to structural studies of antibodies and antibody-antigen complexes. Recent[when? work on apoptosis solves the long-standing problem of how pro-apoptotic Bax changes conformation to dimerise and then oligomerise and permeabilise the mitochondrial membrane, an essential step in the intrinsic cell-death pathway.
Research Interests
Papers共 483 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
DIABETIC MEDICINEno. 4 (2024): e15264-e15264
Christel Hendrieckx,Hanafi M. Husin,Sienna Russell-Green,Jennifer A. Halliday, Benjamin Lam,Steven Trawley,Sybil A. Mcauley,Leon A. Bach,Morton G. Burt,Neale D. Cohen,Peter G. Colman, D. Jane Holmes-Walker,
DIABETES TECHNOLOGY & THERAPEUTICSno. 5 (2024): 335-340
Laura E. Donaldson,Spiros Fourlanos,Sara Vogrin,Richard J. MacIsaac,Peter G. Colman,Sybil A. McAuley
INTERNAL MEDICINE JOURNALno. 1 (2024): 121-128
Michelle S. Miller,Angus D. Cowan,Jason M. Brouwer, Sean T. Smyth,Liuyu Peng,Ahmad Z. Wardak,Rachel T. Uren,Cindy Luo,Michael J. Roy,Sayali Shah, Ziwen Tan,Gavin E. Reid,
The FEBS journal (2024)
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2024)
DIABETES TECHNOLOGY & THERAPEUTICSno. 2 (2024): 87-94
Journal of sleep research (2023)
Annals of Medicineno. 1 (2023): 2198255-2198255
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn